| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| BHC Bausch Health Companies Inc. | 21,765,489,812.3 | 19,264,082,774.17 | 17,087,533,792.94 |
| TSHA Taysha Gene Therapies, Inc. | -1,313,238,695.02 | -1,313,206,209.21 | 5,725,006,022.55 |
| 6472 保瑞 | 688,938,000 | 454,238,000 | 3,696,457,000 |
| AMPH Amphastar Pharmaceuticals, Inc. | 1,667,301,491.23 | 1,388,215,934.55 | 1,711,189,814.72 |
| PSNL Personalis, Inc. | -837,159,212.63 | -960,020,529.75 | 661,865,805.13 |
| 3705 永信 | 327,770,000 | 208,390,000 | 563,414,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | -278,955,613.46 | -278,370,868.96 | 457,075,286.06 |
| 1795 美時 | 701,365,000 | 603,443,000 | 150,870,000 |
| 6461 益得 | -85,138,000 | -98,472,000 | 44,980,000 |
| ASMB Assembly Biosciences Inc | -503,140,158.53 | -503,140,158.53 | 37,878,449.43 |
| CPHI China Pharma Holdings Inc | -1,066,509.0 | 4,431,063.9 | |
| 1720 生達 | 226,316,000 | 98,372,000 | -11,394,000 |
| 6130 上亞科技 | -9,023,000 | -9,023,000 | -13,697,000 |
| SUPN Supernus Pharmaceuticals, Inc. | -156,256,725.37 | -174,708,663.0 | -159,700,220.77 |
| 4120 友華 | -305,129,000 | -376,627,000 | -185,264,000 |
| 4747 強生* | 14,405,000 | 2,196,000 | -765,190,000 |
| RDY Dr. Reddy's Laboratories Limited | -318,459,165.32 | -1,495,418,281.18 | -1,432,207,400.47 |
| TEVA Teva Pharmaceutical Industries Limited | 13,384,151,944.28 | 9,973,142,346.83 | -2,793,779,289.34 |
| BBIO BridgeBio Pharma, Inc. | -2,309,773,270.36 | -2,324,164,482.29 | -6,561,548,004.88 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例